Manufacturer record
Ornate Labs Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
17 batches manufactured by Ornate Labs Pvt. Ltd (Bihar) were declared Not of Standard Quality between June 2019 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
17 records linked to Ornate Labs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets I.P -500 mg | DGT 24-25Mfg 2024-11 · Exp 2026-10 | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab | Oct 2025 |
| Paracetamol Tablets I.P -500 mg | DGT 24-232Mfg 2024-11 · Exp 2026-10 | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab | Oct 2025 |
| Domperidone Suspension IP | DPS3-24- 225Mfg 2024-08 · Exp 2026-07 | Total aerobic viable count under Microbial contamination test and Assay/content of DomperidoneAssay | CDL, KolkataCDSCO lab | Mar 2025 |
| Ciprofloxacin Tablets I.P. 500 mg (Ocif-500) | OCF5-23- 221Mfg 2023-05 · Exp 2025-04 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Aug 2024 |
| Ciprofloxacin Tablets I.P. 500 mg (Ocif- 500 Tablets) | OCF5-23-222Mfg 2023-07 · Exp 2025-06 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2024 |
| Norfloxacin and Tinidazole Tablets (Mt- Nor-TZ), | MTZ22-222Mfg 2022-08 · Exp 2024-07 | Content of Norfloxacin and Tinidazole (ASSAY)Assay | RDTL GuwahatiState lab | Sep 2023 |
| Paracetamol Tablets I.P. 500 mg | DGT22?270Mfg 2022-06 · Exp 2024-05 | DissolutionDissolution | RDTL GuwahatiState lab | May 2023 |
| Zinc Sulphate Oral Solution I.P., 100ml | ZS1-21-224Mfg 2022-01 · Exp 2023-12 | Weight per mlWeight | RDTL GuwahatiState lab | Jan 2023 |
| Prednisolone Tablets I.P. 5 mg | PNT5-22-221Mfg 2022-04 · Exp 2024-03 | DescriptionDescription | CDL KolkataCDSCO lab | Dec 2022 |
| Prednisolone Tablets I.P. 10 mg | PNT10-22-221Mfg 2022-04 · Exp 2024-03 | DescriptionDescription | CDL KolkataCDSCO lab | Dec 2022 |
| Ibuprofen Oral Suspension B.P., 60ml | IPS6-21-221Mfg 2022-02 · Exp 2024-01 | ?pH?pH | RDTL GuwahatiState lab | Nov 2022 |
| Domperidone Suspension IP, 30ml | DPS3-21-221Mfg 2022-01 · Exp 2023-12 | AssayAssay | RDTL GuwahatiState lab | Nov 2022 |
| Albendazole Tablets I.P. 400 mg | AT10-22-245Mfg 2022-07 · Exp 2024-06 | Assay and DissolutionAssay | CDL KolkataCDSCO lab | Oct 2022 |
| Paracetamol Tablets IP 500 mg. | DT21-222Mfg 2021-09 · Exp 2023-08 | Dissolution & AssayAssay | RDTL GuwahatiState lab | Jul 2022 |
| Ciprofloxacin Tablets IP | OCFG5-20-229Mfg 2020-11 · Exp 2022-10 | Assay & DissolutionAssay | RDTL GuwahatiState lab | Jun 2022 |
| Ondansetron Oral Solution IP | GNSG3-18-227Mfg 2019-02 · Exp 2021-01 | AssayAssay | CDTL ChennaiCDSCO lab | Oct 2019 |
| METRONIDAZOLE BENZOATE ORAL SUSPENSION | MNSG18-255Mfg 2018-11 · Exp 2020-10 | Test for MetronidazoleOther | RDTL ChandigarhCDSCO lab | Jun 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.